PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 304.00
+2.00 (0.66%)
Feb 10, 2026, 9:30 AM WIB
IDX:DGNS Income Statement
Financials in millions IDR. Fiscal year is January - December.
Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 157,991 | 163,072 | 145,696 | 192,886 | 302,182 | 183,171 | |
Revenue Growth (YoY) | -2.44% | 11.93% | -24.46% | -36.17% | 64.97% | 256.80% |
Cost of Revenue | 86,545 | 90,998 | 86,384 | 99,127 | 153,626 | 97,692 |
Gross Profit | 71,446 | 72,074 | 59,312 | 93,759 | 148,555 | 85,479 |
Selling, General & Admin | 71,260 | 70,113 | 73,420 | 78,320 | 67,127 | 18,493 |
Other Operating Expenses | -940.47 | 36.37 | 1,043 | -1,660 | - | - |
Operating Expenses | 70,319 | 70,150 | 74,463 | 76,660 | 67,127 | 18,493 |
Operating Income | 1,126 | 1,924 | -15,151 | 17,099 | 81,429 | 66,986 |
Interest Expense | -834.95 | -881.83 | -475.24 | -628.02 | -331.52 | - |
Interest & Investment Income | 65.96 | 107.37 | 392.24 | 862.94 | 2,217 | - |
Other Non Operating Income (Expenses) | - | - | - | - | -35.1 | -10.59 |
EBT Excluding Unusual Items | 357.48 | 1,150 | -15,234 | 17,333 | 83,279 | 66,975 |
Gain (Loss) on Sale of Assets | -316.98 | -285.77 | 1,661 | - | - | - |
Pretax Income | 40.5 | 863.76 | -13,573 | 17,333 | 83,279 | 66,975 |
Income Tax Expense | 2,412 | 116.32 | 83 | 4,669 | 18,975 | 14,289 |
Net Income | -2,372 | 747.44 | -13,656 | 12,665 | 64,304 | 52,687 |
Net Income to Common | -2,372 | 747.44 | -13,656 | 12,665 | 64,304 | 52,687 |
Net Income Growth | - | - | - | -80.31% | 22.05% | 468.07% |
Shares Outstanding (Basic) | 1,250 | 1,250 | 1,250 | 1,250 | 1,240 | 1,000 |
Shares Outstanding (Diluted) | 1,250 | 1,250 | 1,250 | 1,250 | 1,240 | 1,000 |
Shares Change (YoY) | - | - | - | 0.78% | 24.04% | 232.91% |
EPS (Basic) | -1.90 | 0.60 | -10.92 | 10.13 | 51.84 | 52.69 |
EPS (Diluted) | -1.90 | 0.60 | -10.92 | 10.00 | 51.84 | 52.69 |
EPS Growth | - | - | - | -80.71% | -1.60% | 70.64% |
Free Cash Flow | -6,139 | -16,095 | -25,141 | -40,052 | -8,966 | 20,365 |
Free Cash Flow Per Share | -4.91 | -12.88 | -20.11 | -32.04 | -7.23 | 20.36 |
Gross Margin | 45.22% | 44.20% | 40.71% | 48.61% | 49.16% | 46.67% |
Operating Margin | 0.71% | 1.18% | -10.40% | 8.87% | 26.95% | 36.57% |
Profit Margin | -1.50% | 0.46% | -9.37% | 6.57% | 21.28% | 28.76% |
Free Cash Flow Margin | -3.89% | -9.87% | -17.26% | -20.77% | -2.97% | 11.12% |
EBITDA | 12,858 | 13,960 | -3,604 | 26,494 | 86,244 | 69,392 |
EBITDA Margin | 8.14% | 8.56% | -2.47% | 13.74% | 28.54% | 37.88% |
D&A For EBITDA | 11,731 | 12,036 | 11,547 | 9,396 | 4,815 | 2,406 |
EBIT | 1,126 | 1,924 | -15,151 | 17,099 | 81,429 | 66,986 |
EBIT Margin | 0.71% | 1.18% | -10.40% | 8.87% | 26.95% | 36.57% |
Effective Tax Rate | 5956.54% | 13.47% | - | 26.93% | 22.79% | 21.33% |
Advertising Expenses | - | 6,579 | 6,159 | 7,007 | 5,078 | 1,882 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.